Details for: GRASTOFIL
Company: APOTEX INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02441489 | GRASTOFIL | FILGRASTIM | 300 MCG / 0.5 ML | SOLUTION | INTRAVENOUS |
| 02441489 | GRASTOFIL | FILGRASTIM | 300 MCG / 0.5 ML | SOLUTION | SUBCUTANEOUS |
| 02454548 | GRASTOFIL | FILGRASTIM | 480 MCG / 0.8 ML | SOLUTION | INTRAVENOUS |
| 02454548 | GRASTOFIL | FILGRASTIM | 480 MCG / 0.8 ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Summary Basis of Decision
Regulatory Decision Summary
Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome
Regulatory Decision Summary
Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.